<DOC>
	<DOCNO>NCT00638872</DOCNO>
	<brief_summary>The main objective study evaluate efficacy polydeoxyribonucleotide improve heal diabetic foot ulcer .</brief_summary>
	<brief_title>Polydeoxyribonucleotide -Placentex Mastelli ( Pdrn ) Treatment Diabetic Ulcers</brief_title>
	<detailed_description>This trial involve diabetic patient foot ulcer meet inclusion/exclusion criterion . At least 200 patient age 45-80yrs enrol study randomly allocate receive active drug placebo indistinguishable formulation . After 2 month closure rate ulcer evaluate .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Male female age 4580yrs Minimum school 5yrs Type I II diabetes since least 5yrs stable metabolic control Foot ulcer since minimum 2 week Ulcer &gt; 1cm &lt; 16cm day 0 Ulcer grade 1 2 wagner scale Wound free necrotic debris TcPO2 &gt; 29mmHg Not pregnant lactant Nonconsenting patient History alcohol drug abuse Gangrene part affect foot Ongoing untreated infection Ulcer charcot deformity Use systemic cicatrizant drug past 10 day Malnutrition Neurological psychiatric pathology Liver kidney insufficiency Corticosteroid immunosuppressive cytotoxic therapy Other severe pathology Proven hypersensitivity drug relate component</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>foot ulcer</keyword>
	<keyword>polydeoxyribonucleotide</keyword>
</DOC>